Law Office of Brodsky & Smith, LLC Announces Investigation of Gain Capital
BALA CYNWYD, Pa., April 10, 2013
BALA CYNWYD, Pa., April 10, 2013 /PRNewswire/ -- Law office of Brodsky &
Smith, LLC announces that it is investigating potential claims against the
Board of Directors of Gain Capital Holdings LLC ("Gain Capital" or the
"Company") (NYSE: GCAP) relating to the proposed offer received by FXCM, Inc.
Under the proposed transaction, Gain Capital shareholders will receive 0.3996
shares of FXCM Class A common stock for each share of Gain Capital stock they
own. FXCM has also indicated it is prepared to offer up to $50 million in cash
consideration in lieu of FXCM shares. Thereafter, Gain Capital adopted a
stockholder rights plan, which is often called a "poison pill". The
investigation concerns possible breaches of fiduciary duty and other
violations of state law by the Board of Directors of Gain Capital for not
acting in the Company's shareholders' best interests in connection with the
If you own shares of Gain Capital stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions. You may contact
Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC,
Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
http://brodsky-smith.com/563-gcap-gain-capital-holdings-inc.html, by calling
toll free 877-LEGAL-90.
Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Brodsky & Smith, LLC
Press spacebar to pause and continue. Press esc to stop.